Camilla Foged

Best Publications

• Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model

  Camilla Foged;Birger Brodin;Sven Frokjaer;Anne Sundblad

  1008
  Citations

• Opportunities and Challenges in the Delivery of mRNA-based Vaccines.

  Unknown

  552
  Citations

• Delivery of oligonucleotide-based therapeutics: challenges and opportunities.

  Suzan M. Hammond;Annemieke Aartsma-Rus;Sandra Alves;Sven Even F. Borgos

  335
  Citations

• The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.

  Lea Skak Filtenborg Frederiksen;Yibang Zhang;Yibang Zhang;Camilla Foged;Aneesh Thakur

  277
  Citations

• High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

  Unknown

  264
  Citations

• Cell-penetrating peptides for drug delivery across membrane barriers

  Unknown

  258
  Citations

• Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

  Camilla Foged;Carmen Arigita;Anne Sundblad;Wim Jiskoot

  245
  Citations

• The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

  Karen Smith Korsholm;Else Marie Agger;Camilla Foged;Dennis Christensen

  230
  Citations

• Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

  Signe Tandrup Schmidt;Signe Tandrup Schmidt;Camilla Foged;Karen Smith Korsholm;Thomas Rades

  217
  Citations

• Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.

  Unknown

  207
  Citations

• Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.

  Dongmei Cun;Camilla Foged;Mingshi Yang;Sven Frøkjær

  205
  Citations

• Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems

  Unknown

  163
  Citations

• License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems.

  Camilla Foged;Jon Hansen;Else Marie Agger

  142
  Citations

• Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.

  Unknown

  132
  Citations

• Targeting vaccines to dendritic cells.

  Unknown

  129
  Citations

• Elucidating the molecular mechanism of PAMAM-siRNA dendriplex self-assembly: effect of dendrimer charge density.

  Linda B Jensen;Giovanni Maria Pavan;Marina R Kasimova;Sandra Rutherford

  112
  Citations

• Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying.

  Dennis Christensen;Camilla Foged;Ida Rosenkrands;Hanne Mørck Nielsen

  108
  Citations

• Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.

  Pernille Nordly;Fabrice Rose;Dennis Christensen;Hanne Mørck Nielsen

  108
  Citations

• The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.

  Signe Tandrup Schmidt;Swapnil Khadke;Karen Smith Korsholm;Yvonne Perrie

  98
  Citations

• Molecular Characterization of the Interaction between siRNA and PAMAM G7 Dendrimers by SAXS, ITC, and Molecular Dynamics Simulations

  Linda B Jensen;Kell Mortensen;Giovanni Maria Pavan;Marina R Kasimova

  93
  Citations